Business Wire

Landmark Global Galderma Survey Shows 9 out of 10 People Are Affected by Skin Quality Concerns

7.7.2026 07:00:00 CEST | Business Wire | Press release

Share

World’s most extensive skin quality profiling survey of more than 11,000 people across Europe, Asia, and the Americas finds that nine out of ten people are affected by skin quality concerns, with the most important attributes of good skin quality identified as smooth, hydrated and glowing skin1 Results show that skin quality has an impact on quality of life for 85% of people, with more than a third feeling self-conscious, insecure or anxious due to poor skin quality1 In response to clinicians’ calls for a universal assessment tool to help address these concerns, Galderma supported leading experts in the development of the Skin Quality Assessment Scale; a holistic, science-based tool to evaluate skin quality comprehensively and guide personalized, long-term treatment planning2 At Galderma, we champion skin quality by providing insights, tools, and solutions to better understand and address a wide spectrum of concerns, helping people take pride and feel comfortable in their own skin at every stage of life

Galderma (SWX:GALD) has unveiled results from the world’s most extensive skin quality profiling survey, finding that skin quality concerns are widespread, can impact emotional wellbeing and, while differing based on the individual, are often similar among people alike in age, lifestyle, and environment.1 These results underscore the need for effective solutions that can be tailored to a wide variety of skin quality concerns.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706426842/en/

Key findings:1

  • Nine out of ten people globally are affected by skin quality concerns, with each person experiencing an average of two concerns in the past month
  • The most common concerns are fine lines and wrinkles (41%), dry skin (40%), and dull skin (37%), most frequently affecting the face
  • Skin quality impacts quality of life for 85% of people, with more than one in three reporting feelings of self-consciousness, insecurity or anxiety

Skin quality refers to how the skin looks, feels and functions on a day-to-day basis, including its hydration, elasticity, smoothness, radiance, firmness and tone.2 As we age and due to external factors, such as stress, diet, sun exposure, lack of sleep, pollution, or medication-driven weight loss, the amount and quality of the three main components of the skin – hyaluronic acid, elastin and collagen – decrease, leading to a deterioration in skin quality.1,3-6 This is often influenced by geography and culture, and can be accelerated at certain life stages, such as during the menopause, because of hormonal changes.3,4,6,7 Skin quality deterioration reflects visibly across the skin, through a rough or dry texture, an uneven skin tone, or a loss of radiance or firmness.2,3

To gain a detailed understanding of how people perceive skin quality and the concerns that matter most to them, Galderma conducted a survey of more than 11,000 people across 11 countries in four continents: Canada, the United States, Brazil, China, Korea, Thailand, India, France, Germany, Italy, and the United Kingdom. Results showed that skin quality concerns are highly prevalent and important, with nine out of ten people affected and each person experiencing an average of two concerns within the past month.1 The main concerns were fine lines and wrinkles, dry skin, and dull skin – experienced by 41%, 40% and 37% of people, respectively.1 Additionally, age spots, oily skin, decreased firmness and enlarged pores emerged as notable concerns.1 These were found to primarily affect the face, followed by the neck, legs and upper arms.1 Conversely, the most important attributes of good skin quality were smooth, hydrated and glowing skin.1

 

“Our skin evolves over time, influenced by both age and external factors. At Galderma, we don’t believe in one-size-fits-all solutions, we strive to be a trusted partner to people throughout their skin quality journey by offering comprehensive solutions to meet their diverse and evolving needs. This commitment begins with truly understanding these needs, which is why we conducted the world’s most extensive profiling survey to date.”

 

BILL ANDRIOPOULOS, PH.D.
HEAD OF GLOBAL MEDICAL AFFAIRS
GALDERMA

 

 

One in three people feel insecure or anxious due to skin quality concerns1
Skin quality affects more than appearance, influencing emotional wellbeing and shaping how comfortably and confidently people present themselves in their lives.2 Survey results showed that, for 85% of people, skin quality has an impact on their quality of life, with more than a third feeling self-conscious, insecure or anxious due to poor skin quality.1 All skin concerns were described as bothersome, with the most bothersome being scarring, including due to acne, followed by fine lines and wrinkles.1

This discomfort leads most people to either consider or actively seek ways to address skin quality concerns, in particular younger consumers.1 Approximately 70% of 18-34 year olds rated skin quality as eight out of ten in importance, with people most likely to take the first steps to improve the skin quality of their face at the age of 26.1 Respondents were most satisfied with hyaluronic acid injectables as treatments for the most common skin quality concerns of lines and wrinkles (86% very satisfied), dry skin (85%) and dull skin (82%).1

 

“What stood out from these survey insights was not just how common skin quality concerns are, but how they can differ based on age, lifestyle and environment. As clinicians, we see every day how challenging it can be to translate this complexity into meaningful, personalized care. That’s why I was proud to collaborate in the development of the Skin Quality Assessment Scale, an accessible, practical tool to help healthcare professionals and patients work together to create treatment plans that reflect their needs and how these evolve over time.”

 

DR. CHRISTOPH MARTSCHIN
DERMATOLOGIST
LISBON, PORTUGAL

 

 

Addressing patient concerns with the innovative Skin Quality Assessment Scale
To support the accurate assessment and treatment of skin quality concerns, Galderma brought together global dermatology experts to develop the Skin Quality Assessment Scale, the first holistic skin quality assessment tool of its kind.2 The scale helps identify treatment priorities, align expectations, support personalized long-term treatment planning, and track progress over time.2 It was created in response to a clear need identified by healthcare professionals: in a global clinician study, nearly two thirds reported not using any formal tool to assess skin quality, while 81% believed a simple, holistic assessment approach was missing in clinical practice.2 Following its development, 100% of participating clinicians agreed that the Skin Quality Assessment Scale supports a holistic understanding of skin quality, with 98% confirming that it helps guide treatment planning.2

With its decades of expertise in dermatology and aesthetics, and one of the broadest and most diverse portfolios, Galderma is uniquely positioned to address a range of skin quality concerns. Treatments such as Sculptra® and Restylane® Skinboosters™ work together to support skin quality by stimulating collagen and elastin production and enhancing hydration, respectively, helping to improve skin firmness, smoothness and overall radiance.8-17 Galderma designed the Glow on Holistic Individualized Treatment (HIT™) approach to support aesthetic practitioners in combining these two treatments to improve skin quality. Galderma’s Dermatological Skincare flagship brands, Alastin® and Cetaphil®, can also address a broad range of skin quality needs.18-24 The versatile Alastin range is made up of peri-procedural and daily skincare that supports the skin’s regeneration process to help restore a youthful appearance and enhance the visible outcomes of aesthetic and surgical procedures, whereas Cetaphil is designed for those with sensitive skin to help restore, protect and maintain the skin's health every day, building longevity and resilience over time.18-24

Read this report to find out more about how Galderma’s insights, tools, and solutions can support people at every step of their skin quality journey. More insights into the survey results can be found in this infographic.

About Galderma
Galderma (SIX: GALD) is the pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body’s largest organ – the skin – meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we are in shapes our lives, we are advancing dermatology for every skin story. For more information: www.galderma.com.

References

  1. Galderma. Data on file. Skin Quality Consumer Survey.
  2. Martschin C, et al. Development and validation of a novel holistic Skin Quality Assessment Scale. J Cosmet Dermatol. 2025;24(1):e16615. doi: 10.1111/jocd.16615.
  3. Zhang S, Duan E. Fighting against Skin Aging. Cell Transplant. 2018;27(5):729-738. doi: 10.1177/0963689717725755.
  4. Hussein RS, et al. Influences on skin and intrinsic aging: biological, environmental, and therapeutic insights. J Cosmet Dermatol. 2024;24(2):e16688. doi: 10.1111/jocd.16688.
  5. Humphrey CD, Lawrence AC. Implications of Ozempic and other GLP-1 receptor agonists for facial plastic surgeons. Facial Plast Surg. 2023;39(6):719–721. doi: 10.1055/a-2148-6321.
  6. Chylińska N and Maciejczyk M. Hyaluronic acid and skin: its role in aging and wound-healing processes, Gels. 2025;11(4):281. doi: 10.3390/gels11040281.
  7. Reilly DM, Lozano J. Skin collagen through the lifestages: importance for skin health and beauty. Plast Aesthet Res. 2021;8:2. doi: 10.20517/2347-9264.2020.153.
  8. Nikolis A, et al. A comprehensive interim analysis of skin hydration, barrier function (TEWL), elasticity, and patient satisfaction across two treatment arms. Interim Data on File. April 2026.
  9. Waibel J, et al. A randomized, comparative study describing the gene signatures of poly-L-lactic acid (PLLA-SCA) and calcium hydroxylapaptite (CaHA) in the treatment of nasolabial folds. Poster presented at IMCAS World Congress; February 3-6, 2024; Paris, France.
  10. Huth S, et al. Molecular insights into the effects of PLLA-SCA on gene expression and collagen synthesis in human 3d skin models containing macrophages. J Drugs Dermatol. 2024;23(4):285-288. doi: 10.36849/JDD.7791.
  11. Sculptra®. EU Instructions for Use. 2025. Available online. Accessed June 2026.
  12. Fabi S, et al. Effectiveness and safety of correction of cheek wrinkles using a biostimulatory poly-L-lactic acid injectable implant - clinical study data up to 24 months. Poster presented at IMCAS World Congress. January 26-28, 2023; Paris, France.
  13. Bohnert K, et al. Randomized, controlled, multicentered, double-blind investigation of injectable poly-L-Lactic acid for improving skin quality. Plast Reconstr Surg. 2019;127(4):1684–1692. doi: 10.1097/DSS.0000000000001772.
  14. Restylane® Skinboosters Vital Lidocaine™. IFU. August 2022. Available online. Accessed June 2026.
  15. Restylane® Skinboosters Vital Light Lidocaine™. IFU. August 2021. Available online. Accessed June 2026.
  16. Nikolis A, et al. Evaluating the role of small particle hyaluronic acid fillers using micro-droplet technique in the face, neck and hands: a retrospective chart review. Clin Cosmet Investig Dermatol. 2018;11:467–475. doi: 10.2147/CCID.S175408.
  17. Streker M, et al. Stabilized hyaluronic acid-based gel of non-animal origin for skin rejuvenation: face, hand, and decolletage. J Drugs Dermatol. 2013;12(9):990–4. PMID: 24002145.
  18. Gold M, et al. A multi-center clinical trial to evaluate the efficacy of the next generation TriHex Technology antiaging regimen. J Cosmet Dermatol. 2025;24(4):e70192. doi: 10.1111/jocd.70192.
  19. Widgerow AD, et al. Extracellular matrix modulation: optimizing skin care and rejuvenation procedures. J Drugs Dermatol. 2016;15(Suppl 4):s63-s71. PMID: 27050707.
  20. Widgerow AD, et al. Preoperative skin conditioning: extracellular matrix clearance and skin bed preparation, a new paradigm. Aesthet Surg J. 2019;39(Suppl_3):S103-S111. doi: 10.1093/asj/sjz022.
  21. Galderma. Data on file. SPR.3540.207626.
  22. Galderma. Data on file. SPR.3438.207553.
  23. Galderma. Data on file. SPR.3438.207551.
  24. Widgerow AD, et al. Novel strategy for strengthening dermatoporotic skin by managing cellular senescence. J Drugs Dermatol. 2024;23(9):748-756. doi: 10.36849/JDD.8388.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260706426842/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Morinaga Milk Achieves Self-Affirmed GRAS Status for LAC-Living+™, Expanding U.S. Opportunities for Its Postbiotic Ingredient7.7.2026 04:00:00 CEST | Press release

Clinical evidence–backed postbiotic supports mood and well-being with formulation flexibility for diverse applications Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy and functional ingredient company, today announced that it has achieved self-affirmed GRAS (Generally Recognized As Safe) status in the United States for LAC-Living+™ (L. helveticus MCC1848), its proprietary postbiotic ingredient. This milestone expands the commercial availability of LAC-Living+ in the U.S. market and enables its use in dietary supplements, functional foods, and beverages, supporting the development of products designed to address growing consumer demand for health and well-being solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706806943/en/ Growing Interest in Postbiotics and Mental Well-Being Consumer interest in proactive health management has expanded significantly in recent years, alongside increasing aw

Access Advance Welcomes New Licensors to the Video Distribution Patent Pool7.7.2026 02:00:00 CEST | Press release

Access Advance LLC today announced that Sharp, M&K Holdings, Tagivan and 9 other patent owners who own substantial video codec patent portfolios that cover the core technologies behind video decoding, processing, and streaming media delivery, have joined the Video Distribution Patent Pool (VDP Pool) in the first half of 2026. "The addition of all of these new Licensors’ patent portfolios is a real win for both the VDP Pool and our many existing and future Licensees,” said Peter Moller, CEO of Access Advance. “These companies have broad and deep patent portfolios and further enhance the program’s market leading position in resolving the licensing issues around the use of modern video codecs across all the diverse business models of internet video streaming.” The following patent holders have joined the VDP Pool as Licensors in the first half of 2026: Digital Insights Inc. Hanbat National University Industry-Academic Cooperation Foundation Hanwha Vision Co., Ltd. Industry-Academy Coopera

Real Chemistry Announces New Asia Pacific Hub with Acquisition of Spurwing Communications in Singapore7.7.2026 01:00:00 CEST | Press release

Expanded footprint advances the company’s global strategy in key growth region for healthcare and pharma brands Real Chemistry, a global leader in AI- and insights-driven healthcare communications, today announced the acquisition of Spurwing Communications, establishing the company’s first Asia Pacific (APAC) strategic hub in Singapore. This milestone strengthens Real Chemistry’s global strategy and presence in APAC, enhancing its ability to support healthcare organizations. Combining deep market expertise with globally integrated capabilities across analytics, medical communications, advertising and strategic communications, the company is well positioned to deliver more connected, local insight-driven support — ultimately helping clients better reach and engage healthcare professionals, patients and caregivers across the region. “APAC is fast becoming one of the most dynamic and strategically important regions for healthcare innovation and access to life-improving therapies,” said Ka

Vertex to Acquire Crinetics Pharmaceuticals6.7.2026 22:04:00 CEST | Press release

- Crinetics adds potential best-in-class commercialized and Phase 3 endocrinology assets with ~$5 billion peak sales opportunity to Vertex’s portfolio - - PALSONIFY®, Crinetics’ recently launched, first and only, once-daily oral therapy for adults with acromegaly has demonstrated strong and growing early uptake - - Atumelnant, a once-daily oral adrenocorticotropic hormone (ACTH) receptor antagonist in Phase 3 development for congenital adrenal hyperplasia (CAH), has shown unique and transformative potential to both normalize androgen levels and enable management of patients with physiologic levels of glucocorticoids, the true goal of CAH management; atumelnant has also demonstrated therapeutic potential in patients with Cushing’s syndrome - - Acquisition adds to Vertex’s innovation pipeline, accelerates Vertex’s revenue growth and enhances long-term earnings profile - - Vertex to host investor call today, July 6 at 4:30 p.m. ET - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and C

Ciauru Wins the Second Edition of the Reply AI Music Contest, the International Competition Dedicated to Experimentation Across AI, Music and Live Performance6.7.2026 20:30:00 CEST | Press release

The winner was announced on the Kappa FuturFestival stage, following the performances of the five finalists selected by the international jury.German duo PARAFRAME & Avis Vox received the special Reply AI Studios Grand Prix award. The second edition of the Reply AI Music Contest, the international competition created by Reply to explore new forms of expression combining artificial intelligence, music and live performance, concluded with the announcement of the winner on the Nova Stage powered by Reply during Kappa FuturFestival. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706007611/en/ The second edition of the Reply AI Music Contest, the international competition created by Reply to explore new forms of expression combining artificial intelligence, music and live performance, concluded with the announcement of the winner on the Nova Stage powered by Reply during Kappa FuturFestival First place went to Ciauru, the stag

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye